DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 3
- 0 vs. Q3 2022
- Portfolio value
- $3.69M
- −$2.94M (−44.3%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $1.51M | 40.9% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 589,102 | $1.21M | 32.7% | 00.0% | Unchanged | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $976.5K | 26.4% | 00.0% | Unchanged | History |